Approval based on WAYPOINT Phase III results demonstrating reduced nasal polyp severity and nasal congestion, near-elimination of the need for surgery and significantly reduced systematic ...
Funding to support phase 2 trial of INNA-051 aimed at preventing viral respiratory infections ENA Respiratory has raised US$22.4m (AU$34m) in Series B financing to support the phase 2 clinical ...
THOUSAND OAKS, Calif., Oct. 17, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) approved TEZSPIRE ® (tezepelumab-ekko) for the ...
Tezspire (tezepelumab-ekko) is a prescription medicine used to treat inflammatory conditions of the airways, such as severe asthma. The FDA has now approved it as an add-on treatment for adults and ...
Large gatherings and holiday parties with friends and family often mean indulging in delicious food and fun drinks. But for parents of children with food allergies, every dish can feel like a careful ...
EURneffy, a needle-free adrenaline nasal spray, is now available in the UK, offering a portable alternative to traditional auto-injectors for anaphylaxis treatment. Clinical and real-world data ...
It’s hard to think of vaccination without associating it with a sharp jab in the arm. But there are other, more gentle ways of activating the immune system, such as administering vaccines via the nose ...
Amgen and AstraZeneca's Tezspire has claimed FDA approval as a treatment for chronic rhinosinusitis with nasal polyps (CRSwNP), its second indication after severe asthma. The anti-TSLP antibody has ...
New research suggests an over-the-counter nasal spray containing Azelastine may help lower the risk of getting COVID-19. Azelastine may offer some protection against other viruses, too. Doctors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback